161 related articles for article (PubMed ID: 19883972)
1. Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell.
Zhang YH; Wu Q; Xiao XY; Li DW; Wang XP
Cancer Lett; 2010 May; 291(1):76-82. PubMed ID: 19883972
[TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
3. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
Lian C; Yang J; Wang X; Xie Y; Xiao Q
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
[TBL] [Abstract][Full Text] [Related]
4. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
Liu P; Wang TS; You SH; Ge HM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
Zhang T; Guan M; Jin HY; Lu Y
Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
8. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
[TBL] [Abstract][Full Text] [Related]
9. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway.
Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF
Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310
[TBL] [Abstract][Full Text] [Related]
10. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
11. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
12. Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis.
Shi Y; Zhai H; Wang X; Han Z; Liu C; Lan M; Du J; Guo C; Zhang Y; Wu K; Fan D
Exp Cell Res; 2004 Jun; 296(2):337-46. PubMed ID: 15149863
[TBL] [Abstract][Full Text] [Related]
13. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
[TBL] [Abstract][Full Text] [Related]
14. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K
Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472
[TBL] [Abstract][Full Text] [Related]
15. ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines.
Li W; Jie Z; Li Z; Liu Y; Gan Q; Mao Y; Wang X
Mol Med Rep; 2014 Jun; 9(6):2423-8. PubMed ID: 24699918
[TBL] [Abstract][Full Text] [Related]
16. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
[TBL] [Abstract][Full Text] [Related]
17. Mad2beta, an alternative variant of Mad2 reducing mitotic arrest and apoptosis induced by adriamycin in gastric cancer cells.
Yin F; Du Y; Hu W; Qiao T; Ding J; Wu K; Liu Z; Fan D
Life Sci; 2006 Feb; 78(12):1277-86. PubMed ID: 16214181
[TBL] [Abstract][Full Text] [Related]
18. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
19. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells.
Chen Y; Zuo J; Liu Y; Gao H; Liu W
Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
